Related Experiment Video
Updated: Dec 30, 2025
09:19
Strategic Screening and Characterization of the Visual GPCR-mini-G Protein Signaling Complex for Successful Crystallization
Published on: March 16, 2020
7.4K
Continuing challenges in targeting oligomeric GPCR-based drugs.
Joaquin Botta1, Julia Appelhans1, Peter J McCormick1
1Centre for Endocrinology, William Harvey Research Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Progress in Molecular Biology and Translational Science
|January 19, 2020
Summary
Oligomeric G protein-coupled receptor (GPCR) structures show therapeutic promise. Understanding their mechanisms and challenges is key for developing new drug treatments.
Area of Science:
- Biochemistry
- Pharmacology
- Structural Biology
Background:
- G protein-coupled receptors (GPCRs) are crucial drug targets.
- The oligomeric nature of GPCRs is increasingly recognized.
- Oligomeric complexes influence receptor function and signaling.
Purpose of the Study:
- To explore the therapeutic potential of oligomeric GPCR structures.
- To review the history and therapeutic relevance of these complexes.
- To discuss drug targeting strategies for oligomeric GPCRs.
Main Methods:
- Literature review of GPCR oligomerization studies.
- Analysis of therapeutic and theranostic opportunities.
- Examination of oligomer-specific modulation mechanisms.
Main Results:
- Several examples of therapeutically relevant GPCR oligomers identified.
- Mechanisms by which oligomers modulate GPCR function elucidated.
- Challenges in targeting GPCR oligomers highlighted.
Conclusions:
- Oligomeric GPCR structures represent a significant area for therapeutic intervention.
- Targeting these complexes offers novel drug development avenues.
- Overcoming challenges in oligomer-specific targeting is crucial for future treatments.
Related Concept Videos
01:15G Protein-coupled Receptors
16.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
16.1K
01:30Transducer Mechanism: G Protein–Coupled Receptors
3.7K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
3.7K
01:12GPCR Desensitization
7.8K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.8K
01:26Targets for Drug Action: Overview
9.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.9K
01:09GPCRs Regulate Adenylyl Cylase Activity
7.1K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.1K
01:29Drug-Receptor Interactions
7.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.2K